• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies

    Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics

    NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidisciplinary research questions, generate insights, and integrate that information back into their existing Oracle Health and Life Sciences applications. As a result, life sciences organizations can more accurately identify market needs, assess commercial viability, and optimize therapeutic launch strategies. This innovation is yet another step in Oracle's vision to bridge the gap between clinical research and clinical care.

    (PRNewsfoto/Oracle)

    "Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "With Oracle Analytics Intelligence for Life Sciences, we are breaking down the silos that have stifled innovation in the industry and are delivering the tools and intelligence needed to help advance insights and therapies with speed and precision."

    Supported by a wide variety of real-world data sources, such as CancerMPact and multiomics, the platform delivers actionable insights out of the box with pre-built curated datasets, data pipelines, adaptable models, and analytics for determining patient experience, safety monitoring, therapy effectiveness, and brand measurement. Oracle Analytics Intelligence for Life Sciences customers who use the Oracle Learning Health Network will also have continuously updated anonymized Oracle Real World Data (ORWD) available in their analytics environment, which broadens their access to even more information.

    Oracle Analytics Intelligence for Life Sciences is powered by Oracle Health Data Intelligence (HDI). Built on the security and high performance of Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence integrates, secures, and analyzes data from a broad range of sources including electronic health records (EHR), enterprise applications, insurance claims, and demographic records, to provide a more comprehensive view of individual patients and overall population health.

    This proven, EHR-agnostic platform is a continuously learning ecosystem that powers provider applications to support intelligent clinical decision-making, care coordination, and value-based care delivery. With Oracle Analytics Intelligence for Life Sciences, Oracle is now extending this platform to enable clinical research and insight generation, which feeds back into the HDI ecosystem in a continuous learning loop.

    The platform was developed in coordination with Oracle's globally renowned Research Services division, merging cutting-edge technology with deep domain expertise. This collaboration brings together top life sciences experts, including the oncology researchers behind CancerMPact, to deliver a groundbreaking platform that advances insights and therapies with unmatched speed and precision.

    For more information about Oracle Analytics Intelligence for Life Sciences visit: https://www.oracle.com/life-sciences/

    To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-launches-ai-powered-oracle-analytics-intelligence-for-life-sciences-302291197.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is the recent product launched by Oracle for life sciences?

      Oracle has launched the Oracle Analytics Intelligence for Life Sciences, an AI-powered platform designed to unite disparate data sets and accelerate insight generation for life sciences organizations.

    • What types of data sources does the Oracle Analytics Intelligence for Life Sciences utilize?

      The new platform integrates data from various sources, including electronic health records, insurance claims, and demographic records, to provide comprehensive insights on patient experiences and therapy effectiveness.

    • How does Oracle Analytics Intelligence for Life Sciences intend to impact therapeutic launch strategies?

      This platform aims to bridge the gap between clinical research and clinical care, allowing organizations to identify market needs, assess the commercial viability of treatments, and optimize therapeutic launch strategies.

    • What functionalities does the Oracle Analytics Intelligence platform offer to its users?

      The platform supports multidisciplinary research questions and continuously updates insights using real-world data to improve decision-making and patient care outcomes.

    • What is Oracle's broader vision with the introduction of the Analytics Intelligence for Life Sciences?

      The launch is part of Oracle's strategy to modernize clinical research and tightens the connection between research and actual patient care through advanced analytics and data integration.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    9/25/2025$175.00Sell
    Rothschild & Co Redburn
    9/10/2025$410.00Neutral → Buy
    Citigroup
    9/10/2025$368.00Neutral → Buy
    BofA Securities
    9/10/2025$275.00 → $345.00Outperform
    BMO Capital Markets
    9/9/2025$245.00 → $275.00Outperform
    BMO Capital Markets
    7/17/2025$300.00Sector Outperform
    Scotiabank
    7/10/2025$270.00Neutral → Overweight
    Piper Sandler
    7/2/2025$235.00 → $245.00Outperform
    BMO Capital Markets
    More analyst ratings

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Oracle with a new price target

    Rothschild & Co Redburn initiated coverage of Oracle with a rating of Sell and set a new price target of $175.00

    9/25/25 8:33:44 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by Citigroup with a new price target

    Citigroup upgraded Oracle from Neutral to Buy and set a new price target of $410.00

    9/10/25 8:06:16 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by BofA Securities with a new price target

    BofA Securities upgraded Oracle from Neutral to Buy and set a new price target of $368.00

    9/10/25 7:57:28 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle Achieves Swift Compatible Application for Payments 2025

    Empowers customers with secure, standards-based, and future-ready payments solutions for a rapidly evolving market FRANKFURT, Germany, Sept. 29, 2025 /PRNewswire/ -- Oracle Financial Services today announced that Oracle Banking Payments has been validated as a Swift Compatible Application. With this achievement, financial institutions can feel confident in leveraging Oracle's solutions to help meet Swift standards for payment security, interoperability, and regulatory compliance, while benefitting from modern, AI-enabled payment messaging processing. Oracle Banking Payments is

    9/29/25 2:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    New Oracle Government Data Intelligence for Agriculture Helps World Leaders Create More Resilient Food Systems

    AI application securely aggregates and analyzes vast amounts of data to continually provide greater insight into the critical drivers of food security NEW YORK, Sept. 25, 2025 /PRNewswire/ -- United Nations General Assembly -- Helping increase food system resiliency across the globe, Oracle today announced Oracle Government Data Intelligence for Agriculture. Available today, the AI solution provides comprehensive visibility into agricultural data and crop performance so world leaders and government agencies can better monitor production, forecast issues that could lead to food insecurity, and automate response plans to mitigate risk.

    9/25/25 7:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation Announces Promotion of Clay Magouyrk and Mike Sicilia to CEOs; Safra Catz Appointed Executive Vice Chair of the Board of Directors

    AUSTIN, Texas, Sept. 22, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the promotion of Clay Magouyrk and Mike Sicilia to the roles of Chief Executive Officers.  Clay Magouyrk, previously President, Oracle Cloud Infrastructure (OCI), joined Oracle in 2014 from Amazon Web Services. As a founding member of Oracle's cloud engineering team, Clay has overseen the design, implementation and business success of Gen2 of OCI. Oracle Cloud Infrastructure Gen2 is a high-performance, secure, cost-efficient platform that powers both hyperscale public cloud datacenters

    9/22/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Sicilia Michael D.

    4 - ORACLE CORP (0001341439) (Issuer)

    9/26/25 8:27:22 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Chief Executive Officer Magouyrk Clayton M.

    4 - ORACLE CORP (0001341439) (Issuer)

    9/26/25 8:26:12 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    President, Industries Sicilia Michael D. sold $10,869,660 worth of shares (33,845 units at $321.16), converted options into 109,212 shares and covered exercise/tax liability with 52,805 shares, increasing direct ownership by 20% to 132,656 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    9/23/25 9:08:06 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    SEC Filings

    View All

    SEC Form DEFA14A filed by Oracle Corporation

    DEFA14A - ORACLE CORP (0001341439) (Filer)

    9/26/25 5:21:07 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Oracle Corporation

    DEF 14A - ORACLE CORP (0001341439) (Filer)

    9/26/25 5:19:41 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-K filed by Oracle Corporation

    8-K - ORACLE CORP (0001341439) (Filer)

    9/26/25 4:05:13 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    SoftBank Group to Acquire Ampere Computing

    SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

    3/19/25 7:30:00 PM ET
    $CG
    $ORCL
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Meharry Medical College and Oracle Collaborate to Advance Healthcare Access, Innovation, and Education

    Oracle is collaborating with Meharry Medical College regarding technology and resources for students and providers, a research collaborative, and a Meharry established community clinic and wellness center NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle Health and Meharry Medical College today announced plans to improve medical education and community healthcare across Middle Tennessee and beyond. As part of their non-binding MOU, Meharry and Oracle aim to establish a health technology education and research collaborative, a health innovation hub, and a community care and wellness center in Nashville. The two organizations will also work together to cultivate th

    10/30/24 8:55:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Corporation Announces Promotion of Clay Magouyrk and Mike Sicilia to CEOs; Safra Catz Appointed Executive Vice Chair of the Board of Directors

    AUSTIN, Texas, Sept. 22, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the promotion of Clay Magouyrk and Mike Sicilia to the roles of Chief Executive Officers.  Clay Magouyrk, previously President, Oracle Cloud Infrastructure (OCI), joined Oracle in 2014 from Amazon Web Services. As a founding member of Oracle's cloud engineering team, Clay has overseen the design, implementation and business success of Gen2 of OCI. Oracle Cloud Infrastructure Gen2 is a high-performance, secure, cost-efficient platform that powers both hyperscale public cloud datacenters

    9/22/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Announces Fiscal Year 2026 First Quarter Financial Results

    Q1 Remaining Performance Obligations $455 billion, up 359% in both USD and constant currencyQ1 GAAP Earnings per Share down 2% to $1.01, Non-GAAP Earnings per Share up 6% to $1.47Q1 Total Revenue $14.9 billion, up 12% in USD and up 11% in constant currencyQ1 Cloud Revenue (IaaS plus SaaS) $7.2 billion, up 28% in USD and up 27% in constant currency Q1 Cloud Infrastructure (IaaS) Revenue $3.3 billion, up 55% in USD and up 54% in constant currency Q1 Cloud Application (SaaS) Revenue $3.8 billion, up 11% in USD and up 10% in constant currencyQ1 Fusion Cloud ERP (SaaS) Revenue $1.0 billion, up 17% in USD and up 16% in constant currencyQ1 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 16% in U

    9/9/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its First Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on September 9, 2025, After the Close of the Market AUSTIN, Texas, Sept. 2, 2025 /PRNewswire/ -- Oracle Corporation today announced that its first quarter fiscal year 2026 results will be released on Tuesday, September 9th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, auton

    9/2/25 4:01:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology